Related Experiment Video
Updated: Aug 6, 2026

05:39
Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Published on: February 9, 2021
Near-Infrared Light Photocatalysis Enables Synergistic Cancer Therapy
Jian-Qing Zhang1, Piao-Piao Yang-Liu1, Chun-Ying Zhuang1
1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Angewandte Chemie (International Ed. in English)
|July 24, 2026
Summary
This study introduces a new near-infrared (NIR) photocatalyst for cancer therapy. This novel material generates reactive oxygen species and disrupts tumor redox balance, leading to effective cancer treatment and immune activation.
Area of Science:
- Biomedical Engineering
- Photochemistry
- Oncology
Background:
- Photocatalysis in living systems is limited by poor light penetration of UV/visible light into tissues.
- Developing photocatalysts that utilize near-infrared (NIR) light is crucial for deep-tissue therapeutic applications.
Purpose of the Study:
- To develop a novel NIR photocatalyst for enhanced cancer therapy.
- To investigate the dual-action mechanism of the photocatalyst involving reactive oxygen species generation and NADH oxidation.
- To evaluate the therapeutic efficacy of the photocatalyst in tumor treatment and immune activation.
Main Methods:
- Conjugation of a Pt(II) porphyrin with a cyanine dye to create an NIR photocatalyst.
- Utilizing 808 nm irradiation to activate the photocatalyst.
- Investigating dual energy/electron-transfer pathways for reactive oxygen species (ROS) generation (singlet oxygen, superoxide radical, hydroxyl radical) and NADH oxidation.
- Formulating the photocatalyst into biocompatible nanoparticles for delivery.
- Employing fluorescence (FL) and photoacoustic (PA) imaging for tumor delineation.
- Assessing the induction of immunogenic cell death and activation of tumor-specific cytotoxic T cells.
Main Results:
- The developed NIR photocatalyst effectively generates ROS and oxidizes NADH upon 808 nm irradiation.
- The dual action disrupts cellular redox balance, inducing immunogenic cell death.
- Biocompatible nanoparticles enabled precise tumor delineation via FL/PA imaging.
- The treatment activated tumor-specific cytotoxic T cells, inhibiting both primary and distant tumor growth.
- High therapeutic efficiency was achieved in impeding tumor progression.
Conclusions:
- This work establishes a novel NIR photocatalytic strategy for synergistic cancer therapy.
- The dual-action mechanism offers a promising approach for disrupting tumor redox balance and inducing an anti-tumor immune response.
- The developed system demonstrates potential for precise tumor imaging and effective treatment, highlighting its translational value.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

